Regulation of squalene epoxidase in HepG2 cells.

Regulation of squalene epoxidase in the cholesterol biosynthetic pathway was studied in a human hepatoma cell line, HepG2 cells. Since the squalene epoxidase activity in cell homogenates was found to be stimulated by the addition of Triton X-100, enzyme activity was determined in the presence of thi...

Full description

Bibliographic Details
Main Authors: Y Hidaka, T Satoh, T Kamei
Format: Article
Language:English
Published: Elsevier 1990-11-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520422734
_version_ 1818590509905477632
author Y Hidaka
T Satoh
T Kamei
author_facet Y Hidaka
T Satoh
T Kamei
author_sort Y Hidaka
collection DOAJ
description Regulation of squalene epoxidase in the cholesterol biosynthetic pathway was studied in a human hepatoma cell line, HepG2 cells. Since the squalene epoxidase activity in cell homogenates was found to be stimulated by the addition of Triton X-100, enzyme activity was determined in the presence of this detergent. Incubation of HepG2 cells for 18 h with L-654,969, a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, increased squalene epoxidase activity dose-dependently. On the other hand, low density lipoprotein (LDL) and 25-hydroxy-cholesterol decreased the enzyme activity. These results demonstrate that squalene epoxidase is regulated by the concentrations of endogenous and exogenous sterols. The affinity of the enzyme for squalene was not changed by treatment with L-654,969. Cytosolic (S105) fractions, prepared from HepG2 cells treated with or without L-654,969, had no effect on microsomal squalene epoxidase activity of HepG2 cells, in contrast to the stimulating effect of S105 fractions from rat liver homogenate. Mevalonate, LDL, and oxysterol treatment abolished the effect of L-654,969. Simultaneous addition of cycloheximide and actinomycin D also prevented enzyme induction in HepG2 cells. From these results, the change in squalene epoxidase activity is thought to be caused by the change in the amount of enzyme protein. It is further suggested that squalene epoxidase activity is suppressed only by sterols, not by nonsterol derivative(s) of mevalonate, in contrast to the regulation of HMG-CoA reductase.
first_indexed 2024-12-16T09:57:41Z
format Article
id doaj.art-e4028204c9164f53948a9b6d17c4a731
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-16T09:57:41Z
publishDate 1990-11-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-e4028204c9164f53948a9b6d17c4a7312022-12-21T22:35:53ZengElsevierJournal of Lipid Research0022-22751990-11-01311120872094Regulation of squalene epoxidase in HepG2 cells.Y Hidaka0T Satoh1T Kamei2Central Research Laboratories, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.Central Research Laboratories, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.Central Research Laboratories, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.Regulation of squalene epoxidase in the cholesterol biosynthetic pathway was studied in a human hepatoma cell line, HepG2 cells. Since the squalene epoxidase activity in cell homogenates was found to be stimulated by the addition of Triton X-100, enzyme activity was determined in the presence of this detergent. Incubation of HepG2 cells for 18 h with L-654,969, a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, increased squalene epoxidase activity dose-dependently. On the other hand, low density lipoprotein (LDL) and 25-hydroxy-cholesterol decreased the enzyme activity. These results demonstrate that squalene epoxidase is regulated by the concentrations of endogenous and exogenous sterols. The affinity of the enzyme for squalene was not changed by treatment with L-654,969. Cytosolic (S105) fractions, prepared from HepG2 cells treated with or without L-654,969, had no effect on microsomal squalene epoxidase activity of HepG2 cells, in contrast to the stimulating effect of S105 fractions from rat liver homogenate. Mevalonate, LDL, and oxysterol treatment abolished the effect of L-654,969. Simultaneous addition of cycloheximide and actinomycin D also prevented enzyme induction in HepG2 cells. From these results, the change in squalene epoxidase activity is thought to be caused by the change in the amount of enzyme protein. It is further suggested that squalene epoxidase activity is suppressed only by sterols, not by nonsterol derivative(s) of mevalonate, in contrast to the regulation of HMG-CoA reductase.http://www.sciencedirect.com/science/article/pii/S0022227520422734
spellingShingle Y Hidaka
T Satoh
T Kamei
Regulation of squalene epoxidase in HepG2 cells.
Journal of Lipid Research
title Regulation of squalene epoxidase in HepG2 cells.
title_full Regulation of squalene epoxidase in HepG2 cells.
title_fullStr Regulation of squalene epoxidase in HepG2 cells.
title_full_unstemmed Regulation of squalene epoxidase in HepG2 cells.
title_short Regulation of squalene epoxidase in HepG2 cells.
title_sort regulation of squalene epoxidase in hepg2 cells
url http://www.sciencedirect.com/science/article/pii/S0022227520422734
work_keys_str_mv AT yhidaka regulationofsqualeneepoxidaseinhepg2cells
AT tsatoh regulationofsqualeneepoxidaseinhepg2cells
AT tkamei regulationofsqualeneepoxidaseinhepg2cells